NCT07166367 2025-09-10Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast CancerNational Cancer Centre, SingaporePhase 2 Terminated3 enrolled
NCT05511844 2025-07-04Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid TumorsOrum Therapeutics USA, Inc.Phase 1 Terminated25 enrolled